These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9315116

  • 1. Immune responses in mice after gastric and subcutaneous immunization with BCG.
    Ibsen MW, Bakken V, Jonsson R, Hordnes K.
    Scand J Immunol; 1997 Sep; 46(3):274-80. PubMed ID: 9315116
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 4. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, Slobbe L, Collins DM, de Lisle GW, Buddle BM.
    Immunology; 2003 Apr 01; 108(4):548-55. PubMed ID: 12667217
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M, Xia ZY, Bao L.
    Cell Immunol; 2013 Apr 01; 285(1-2):111-7. PubMed ID: 24177251
    [Abstract] [Full Text] [Related]

  • 6. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS.
    Infect Immun; 2007 Jun 01; 75(6):2833-40. PubMed ID: 17371857
    [Abstract] [Full Text] [Related]

  • 7. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.
    Wang J, Zganiacz A, Xing Z.
    Vaccine; 2002 Jul 26; 20(23-24):2887-98. PubMed ID: 12126899
    [Abstract] [Full Text] [Related]

  • 8. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
    Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M.
    Infect Immun; 1996 Jan 26; 64(1):1-9. PubMed ID: 8557324
    [Abstract] [Full Text] [Related]

  • 9. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH, Sun Z, Yang XL, Bao L.
    Scand J Immunol; 2010 Oct 26; 72(4):332-8. PubMed ID: 20883318
    [Abstract] [Full Text] [Related]

  • 10. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
    Tang Q, Dou J, Zhao FS, Chu LL, Pan M, Wang YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul 26; 23(7):591-4. PubMed ID: 17618574
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice.
    Bonanni D, Rindi L, Lari N, Garzelli C.
    J Med Microbiol; 2005 May 26; 54(Pt 5):443-448. PubMed ID: 15824420
    [Abstract] [Full Text] [Related]

  • 12. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M.
    Clin Immunol; 2008 Dec 26; 129(3):492-8. PubMed ID: 18849196
    [Abstract] [Full Text] [Related]

  • 13. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice.
    Petricevich VL, Ueda C, Alves RC, da Silva MA, Moreno C, Melo AR, Dias da Silva W.
    Braz J Med Biol Res; 2001 Jan 26; 34(1):81-92. PubMed ID: 11151032
    [Abstract] [Full Text] [Related]

  • 14. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H, Peng P, Miao S, Zhao Y, Mao F, Wang L, Bai Y, Xu Z, Wei S, Shi C.
    Scand J Immunol; 2010 Oct 26; 72(4):349-57. PubMed ID: 20883320
    [Abstract] [Full Text] [Related]

  • 15. Murine cytokine responses following multiple oral immunizations using lipid-formulated mycobacterial antigens.
    Cross ML, Lambeth MR, Aldwell FE.
    Immunol Cell Biol; 2008 Feb 26; 86(2):214-7. PubMed ID: 17998917
    [Abstract] [Full Text] [Related]

  • 16. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.
    Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C.
    Infect Immun; 2002 Dec 26; 70(12):6549-57. PubMed ID: 12438324
    [Abstract] [Full Text] [Related]

  • 17. Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice.
    Kawamura I, Yang J, Takaesu Y, Fujita M, Nomoto K, Mitsuyama M.
    Infect Immun; 1994 Oct 26; 62(10):4396-403. PubMed ID: 7927701
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice.
    Lagranderie M, Chavarot P, Balazuc AM, Marchal G.
    Vaccine; 2000 Jan 18; 18(13):1186-95. PubMed ID: 10649619
    [Abstract] [Full Text] [Related]

  • 19. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
    Logan KE, Chambers MA, Hewinson RG, Hogarth PJ.
    Vaccine; 2005 Dec 01; 23(48-49):5526-32. PubMed ID: 16105710
    [Abstract] [Full Text] [Related]

  • 20. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA, Shklovskaya E, Spratt J, Ryan AA, Palendira U, Fazekas de St Groth B, Britton WJ.
    Infect Immun; 2007 Nov 01; 75(11):5368-75. PubMed ID: 17724075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.